CICA-Exo™ Technology: The Science Behind Veranum's Cica

You've seen "Centella asiatica" on a hundred skincare labels. What most labels don't tell you is that there's an enormous gap between a basic centella extract and a clinical-grade cica active. CICA-Exo technology is what closes that gap — an exosome-based delivery system that gets centella's most active triterpenes deeper, faster, and at a meaningful concentration. This is the science.

What's actually in centella, and why most extracts underdeliver

Centella asiatica's value comes from four molecules collectively known as the TECA complex: asiatic acid, madecassic acid, asiaticoside, and madecassoside. These triterpenes drive nearly everything centella is famous for — wound-healing acceleration, fibroblast stimulation, anti-inflammatory action, and a documented increase in type I and type III collagen synthesis. The dermatology literature on madecassoside alone runs to hundreds of papers, including peer-reviewed studies on UVB protection, post-procedure recovery, and barrier reinforcement.

The catch: a generic centella extract is mostly inert plant material. The TECA actives sit at single-digit percentages of total extract weight, and they're large, hydrophobic molecules — meaning they don't penetrate the stratum corneum well on their own. Slap a 5% centella extract on the side of a moisturizer's INCI list and you're delivering a fraction of a fraction of the actual repair compounds. Most "cica" products on the global market are exactly this: real centella, real label, real underperformance.

Enter CICA-Exo: exosome-based delivery

Exosomes are nano-scale lipid vesicles — about 30–150 nanometers across — that cells naturally produce to carry signaling molecules to other cells. In dermatology, exosomes have become one of the most active research areas of the last five years, with studies showing they can deliver peptides, growth factors, and plant actives across the stratum corneum at concentrations small-molecule formulations can't match.

CICA-Exo is Veranum's proprietary application of this principle to centella. Instead of relying on a passive extract, the TECA triterpenes are encapsulated inside biocompatible exosome carriers. Three things change as a result:

• Penetration depth. Exosomes cross the lipid layers of the stratum corneum that block free triterpenes, delivering madecassoside and asiaticoside to the viable epidermis where fibroblasts actually live.
• Effective concentration. Encapsulation protects the actives from oxidation between formulation and skin contact, so the percentage on the label is closer to the percentage on the cell surface.
• Sustained release. Exosomal carriers release their cargo over hours rather than minutes, which matches the timescale of repair signaling.

Centella delivery systems compared

The net result is a cica product that behaves more like a clinical post-procedure protocol than a comforting plant cream. You feel it because more of the active is actually there.

Why this matters for repair, redness, and barrier work

The reason exosome delivery for centella matters in everyday skincare — not just in clinical post-procedure care — is that almost every "skin problem" most adults deal with maps back to a chronic low-grade inflammatory cascade. Barrier damage, persistent redness, slow healing of post-acne marks, even some forms of hyperpigmentation share the same upstream signal: NF-κB activation, IL-6 and TNF-α production, prostaglandin overproduction.

Madecassoside has been shown to attenuate that cascade at multiple points. Asiaticoside specifically accelerates fibroblast migration into wound sites. When CICA-Exo delivers both molecules at depth, you're not just calming the surface of the skin — you're addressing the signaling layer underneath. That's why a properly formulated cica ampoule can do the work of three separate "anti-redness," "barrier repair," and "post-acne" products.

What CICA-Exo isn't

A few honest clarifications, because the exosome category attracts a lot of marketing fog. CICA-Exo isn't a stem cell product. It's not a human-derived exosome (those exist, primarily in clinical settings, and carry their own regulatory considerations). It isn't a "growth factor" in the medical sense. It's a delivery system for plant-derived triterpenes that already have decades of dermatology research behind them. The exosome science upgrades how those actives get to your skin — it doesn't change what they are.

That distinction matters because it tells you what to expect. CICA-Exo isn't going to feel like a magic single-application result. What it feels like is consistent, compounding repair — less redness week over week, faster fade on post-acne marks, a barrier that stops reacting to weather changes. The kind of "boring" outcome that means the active actually arrived.

How to tell if a cica product is doing something

If you're shopping cica products beyond Veranum, three diagnostics tell you a lot. First, look for named TECA components on the INCI — madecassoside, asiaticoside, asiatic acid, madecassic acid — not just "centella asiatica leaf extract." Second, look for delivery language: encapsulation, liposomal, exosomal, nanoemulsion. Third, give a cica product four to six weeks of consistent use before judging it. The repair pathway it activates compounds slowly and the difference between "this isn't working" and "this is working" often shows up in week three or four, not week one.

Frequently asked questions

The short version

Centella asiatica is real medicine. Most centella products underdeliver because the active triterpenes don't penetrate well from a basic extract. CICA-Exo encapsulates those triterpenes in exosome carriers, getting more of the active deeper into the skin where it can actually do repair work. That's the science behind every Veranum cica ampoule, and it's the reason a Veranum routine produces results most other cica routines hint at but don't quite hit.